Literature DB >> 7925997

Phosphorylation of JAK2 in thrombin-stimulated human platelets.

B Rodríguez-Liñares, S P Watson.   

Abstract

We show the presence of the tyrosine kinase JAK2 in human platelets and demonstrate that it undergoes phosphorylation on tyrosine residues on challenge with the G protein receptor stimulus, thrombin, or the tyrosine phosphatase inhibitor, peroxovanadate. Thrombin-induced phosphorylation of JAK2 is inhibited by two structurally distinct inhibitors of tyrosine kinases, staurosporine and the tyrphostin ST271. The protein kinase C (PKC) inhibitor, Ro 31-8220, and intracellular Ca2+ chelator, BAPTA-AM, also inhibit thrombin-induced phosphorylation of JAK2, while the phorbol ester, phorbol dibutyrate (PDBu), and Ca2+ ionophore, A23187, induce tyrosine phosphorylation of JAK2. These results suggest that tyrosine phosphorylation of JAK2 stimulated by thrombin may be mediated downstream of phosphoinositide metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925997     DOI: 10.1016/0014-5793(94)00983-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  α(1A)-adrenergic receptor differentially regulates STAT3 phosphorylation through PKCϵ and PKCδ in myocytes.

Authors:  Ting Shi; Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2012-01-24       Impact factor: 2.092

2.  Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae.

Authors:  H Ju; V J Venema; H Liang; M B Harris; R Zou; R C Venema
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

Review 3.  The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth.

Authors:  B Schieffer; K E Bernstein; M B Marrero
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

Review 4.  Cellular consequences of thrombin-receptor activation.

Authors:  R J Grand; A S Turnell; P W Grabham
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

5.  Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases.

Authors:  J Cohen; H Altaratz; Y Zick; U Klingmüller; D Neumann
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

Review 6.  Regulation of mast cell-mediated innate immunity during early response to bacterial infection.

Authors:  Ravi Malaviya; Amara Georges
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 7.  Ligand-directed signalling at beta-adrenoceptors.

Authors:  Bronwyn A Evans; Masaaki Sato; Mohsin Sarwar; Dana S Hutchinson; Roger J Summers
Journal:  Br J Pharmacol       Date:  2010-02-02       Impact factor: 8.739

8.  Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors.

Authors:  Stéphane Pelletier; François Duhamel; Philippe Coulombe; Michel R Popoff; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 9.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

10.  Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function.

Authors:  Iván Parra-Izquierdo; Alexander R Melrose; Jiaqing Pang; Hari Hara Sudhan Lakshmanan; Stéphanie E Reitsma; Sai Hitesh Vavilapalli; Mark K Larson; Joseph J Shatzel; Owen J T McCarty; Joseph E Aslan
Journal:  Platelets       Date:  2021-06-07       Impact factor: 4.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.